Show simple item record

dc.contributor.authorAntony, Thomas
dc.contributor.authorFerreira, Katrina
dc.date.accessioned2020-11-17T15:57:45Z
dc.date.available2020-11-17T15:57:45Z
dc.date.issued2019-10-01
dc.identifier.other16772410
dc.identifier.urihttps://hdl.handle.net/1813/74359
dc.description.abstract[Excerpt] M&A activities are deeply embedded into the culture of the pharmaceutical industry as a whole. Based upon a survey of pharmaceutical executives, 50% anticipate their M&A activity will drive between a quarter and half of projected growth in the next two years. Such deals within the pharmaceutical industry help firms find potential synergies, increase cooperation in areas of operational capabilities as well as transfer of functional and managerial capabilities between merging firms. However, when it comes to post merger integration efforts, companies may overlook various people, process and technological factors that can hamper M&As efforts and worse yet, cripple such a transaction from achieving desired results. A survey done by Deloitte found that respondents believed that effective integration efforts was one of the important factors for a successful M&A transaction, with 23% respondents reporting it. It is critical for companies considering an M&A or in the process of such a transition to consider the major pitfalls that may occur post-merger and prepare mitigation strategies in order to support firm-wide initiatives around integration.
dc.language.isoen_US
dc.rightsRequired Publisher Statement: Copyright held by the authors.
dc.subjectHuman Resources
dc.subjectchange management
dc.subjectmergers and acquisitions
dc.subjectM&A
dc.subjectpharmaceutical
dc.subjectbest practices
dc.subjectHR
dc.subjectdata
dc.subjectchange agent
dc.subjectmergers
dc.subjectacquisitions
dc.titleWhat are Some Industry Best Practices, Potential Risks, and Benchmark Data to Help Support Change Management During Large Mergers and Acquisitions (M&As) Within the Pharmaceutical Industry?
dc.typearticle
dc.description.legacydownloadsBest_Practices_Risks_and_Benchmark_Data_for_Change_Management_During_M___As_in_the_Pharma_Industry.pdf: 54 downloads, before Oct. 1, 2020.
local.authorAffiliationAntony, Thomas: Cornell University
local.authorAffiliationFerreira, Katrina: Cornell University


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics